Prior treatments included topical and oral steroids, systemic antibiotics and antifungals, nystatin powder, A+D Ointment (Schering-Plough Kenilworth, NJ), and three different topical clotrimazole ...

As an example, both market share and sales of mometasone furoate (Nasonex; Schering–Plough) increased after the entry of generic fluticasone in the United States, according to the 2007 company ...

and Merck–Schering-Plough ($41 billion). Taking this into account, the remaining spending of $34 billion represents a reduction of around 30% compared with 2008. From a strategic perspective ...